NCT05106465Completed
A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and Magnetic Resonance Imaging (MRI) Measures of Brain Tissue Damage
Konect-MF: A Study to Explore Association Patterns Between Digital Outcome Assessments From the Konectom™ Platform and MRI Measures of Brain Tissue Damage
Source: ClinicalTrials.gov · Last updated 17 May 2024
Brief summary (registry, in English)
The purpose of the study is to explore association patterns between digital outcome assessments from Konectom and MRI measures of brain tissue damage.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 200 (actual)
- First submitted
- 20 Oct 2021
- Start date
- 15 Dec 2021
- Primary completion date
- 3 Apr 2024
- Lead sponsor
- Biogen
- Diseases
- Multiple sclerosis
- NCT number
- NCT05106465
What you commit to
- Study type: Observational
- Participants enrolled: 200
- From 15 Dec 2021 to the primary completion date, 3 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Unable or unwilling to provide informed consent.
- Inability to use a smartphone as per physician's opinion.
- Not owning a Konectom-compatible smartphone.
- Other unspecified reasons that, in the opinion of the Investigator or Biogen, make the participant unsuitable for participation in the sub-study. A participant only needs to complete the assessments deemed necessary by the Investigator.
- NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.
Who the study is looking for
- Should be enrolled in multiple sclerosis partners advancing technology and health solutions (MS PATHS).
- Participant (or participant's legal representative) has the ability to understand the purpose and risks of the study, to provide signed and dated informed consent, and to authorize the use of confidential health information in accordance with national and local privacy regulations.
- Should have literacy of written language in which the software and Instructions for use are displayed (User Interface \[UI\], Instructions).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Multiple Sclerosis Centre Coordinator of this site? Confirm its status | Dresden | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.